Serum nitric oxide metabolists in bronchial asthma patients

F. Nina, K. Lubov (Saint-Petersburg, Russian Federation)

Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Session: Allergy and immunology of asthma and beyond
Session type: Thematic Poster Session
Number: 3738
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Nina, K. Lubov (Saint-Petersburg, Russian Federation). Serum nitric oxide metabolists in bronchial asthma patients. Eur Respir J 2008; 32: Suppl. 52, 3738

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Changes in nitric oxide production in patients with bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 588s
Year: 2007

Features of production nitric oxide at patients with a bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Increased nitric oxide production by neutrophils in bronchial asthma
Source: Eur Respir J 2001; 17: 868-871
Year: 2001



Serum nitrotyrosine and nitric oxide levels in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 424s
Year: 2002

Exhaled nitric oxide in asthma
Source: Eur Respir Monogr 2010; 49: 32-44
Year: 2010


Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Increased exhaled nitric oxide in nonatopic asthma
Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air
Year: 2003


The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

Levels of asthma control and exhaled nitric oxide
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Exhaled nitric oxide in children with severe asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012


Changes in nitric oxide production in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006

Exhaled nitric oxide and bronchial hyperresponsiveness in steroid-naive patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002

Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Superiority of hydrogen peroxide to exhaled nitric oxide as a marker of bronchial inflammation in asthmatic children
Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring
Year: 2008


Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002



Exhaled nitric oxide and cough variant asthma
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009


Exhaled nitric oxide and pulmonary function tests in children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 759s
Year: 2007

Diagnosing asthma using exhaled nitric oxide (eNO) measurements
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003